248 related articles for article (PubMed ID: 29222436)
1. Weekly self-measurement of FEV1 and PEF and its impact on ACQ (asthma control questionnaire)-scores: 12-week observational study with 76 patients.
Werner CU; Linde K; Schäffner J; Storr C; Schneider A
NPJ Prim Care Respir Med; 2017 Dec; 27(1):64. PubMed ID: 29222436
[TBL] [Abstract][Full Text] [Related]
2. [Assessment of the simplified versions of the Asthma Control Questionnaire].
Badiola C; Badia X; Sastre J; Olaguibel JM; López-Viña A; Vega JM; Picado C;
Med Clin (Barc); 2008 Sep; 131(9):326-32. PubMed ID: 18817649
[TBL] [Abstract][Full Text] [Related]
3. Cut-off points for defining asthma control in three versions of the Asthma Control Questionnaire.
Sastre J; Olaguibel J; Vega JM; Del Pozo V; Picado C; Lopez Viña A
J Asthma; 2010 Oct; 47(8):865-70. PubMed ID: 20846084
[TBL] [Abstract][Full Text] [Related]
4. Comparison between peak expiratory flow and forced expiratory volume in one second (FEV1) during bronchoconstriction induced by different stimuli.
Giannini D; Paggiaro PL; Moscato G; Gherson G; Bacci E; Bancalari L; Dente FL; Di Franco A; Vagaggini B; Giuntini C
J Asthma; 1997; 34(2):105-11. PubMed ID: 9088296
[TBL] [Abstract][Full Text] [Related]
5. Comparison of serial monitoring of peak expiratory flow and FEV1 in the diagnosis of occupational asthma.
Leroyer C; Perfetti L; Trudeau C; L'Archevĕque J; Chan-Yeung M; Malo JL
Am J Respir Crit Care Med; 1998 Sep; 158(3):827-32. PubMed ID: 9731012
[TBL] [Abstract][Full Text] [Related]
6. Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV
Halpin DMG; Meltzer EO; Pisternick-Ruf W; Moroni-Zentgraf P; Engel M; Zaremba-Pechmann L; Casale T; FitzGerald JM
Respir Res; 2019 Jul; 20(1):159. PubMed ID: 31319851
[TBL] [Abstract][Full Text] [Related]
7. Association Between Pulmonary Function and Asthma Symptoms.
Sullivan PW; Ghushchyan VH; Marvel J; Barrett YC; Fuhlbrigge AL
J Allergy Clin Immunol Pract; 2019; 7(7):2319-2325. PubMed ID: 31034996
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic and screening capacities of peak expiratory flow measurements in the assessment of airway obstruction and bronchodilator response in children with asthma.
Slieker MG; van der Ent CK
Monaldi Arch Chest Dis; 2003; 59(2):155-9. PubMed ID: 14635506
[TBL] [Abstract][Full Text] [Related]
9. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Once-Daily Tiotropium Respimat® Is Well Tolerated and Maintains Efficacy over 52 Weeks in Patients with Symptomatic Asthma in Japan: A Randomised, Placebo-Controlled Study.
Ohta K; Ichinose M; Tohda Y; Engel M; Moroni-Zentgraf P; Kunimitsu S; Sakamoto W; Adachi M
PLoS One; 2015; 10(4):e0124109. PubMed ID: 25894430
[TBL] [Abstract][Full Text] [Related]
11. Relationship between airway obstruction and respiratory symptoms in adult asthmatics.
Teeter JG; Bleecker ER
Chest; 1998 Feb; 113(2):272-7. PubMed ID: 9498938
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study.
Lee YS; Lin HC; Huang CD; Lee KY; Liu CY; Yu CT; Wang CH; Kuo HP
Chang Gung Med J; 2011; 34(4):382-94. PubMed ID: 21880193
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of current asthma control using ACQ and ACT compared with GINA criteria.
Korn S; Both J; Jung M; Hübner M; Taube C; Buhl R
Ann Allergy Asthma Immunol; 2011 Dec; 107(6):474-9. PubMed ID: 22123375
[TBL] [Abstract][Full Text] [Related]
14. Classification of asthma severity: should the international guidelines be changed?
Sawyer G; Miles J; Lewis S; Fitzharris P; Pearce N; Beasley R
Clin Exp Allergy; 1998 Dec; 28(12):1565-70. PubMed ID: 10024229
[TBL] [Abstract][Full Text] [Related]
15. Stratifying a risk for an increased variation of airway caliber among the clinically stable asthma.
Hayata A; Matsunaga K; Hirano T; Akamatsu K; Ichikawa T; Minakata Y; Ichinose M
Allergol Int; 2013 Sep; 62(3):343-9. PubMed ID: 23880616
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of web-based versus standard asthma self-management.
Araújo L; Jacinto T; Moreira A; Castel-Branco MG; Delgado L; Costa-Pereira A; Fonseca J
J Investig Allergol Clin Immunol; 2012; 22(1):28-34. PubMed ID: 22448451
[TBL] [Abstract][Full Text] [Related]
17. Increased body mass index does not lead to a worsening of asthma control in a large adult asthmatic population in Spain.
Sastre J; Olaguíbel JM; López Viña A; Vega JM; del Pozo V; Picado C
J Investig Allergol Clin Immunol; 2010; 20(7):551-5. PubMed ID: 21313994
[TBL] [Abstract][Full Text] [Related]
18. Which index of peak expiratory flow is most useful in the management of stable asthma?
Reddel HK; Salome CM; Peat JK; Woolcock AJ
Am J Respir Crit Care Med; 1995 May; 151(5):1320-5. PubMed ID: 7735580
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis.
Tirimanna PR; Den Otter JJ; Van Schayck CP; Van Herwaarden CL; Folgering H; Van Weel C
Br J Gen Pract; 1996 Jan; 46(402):15-8. PubMed ID: 8745846
[TBL] [Abstract][Full Text] [Related]
20. Difference in time-course of improvement in asthma control measures between budesonide and budesonide/formoterol.
Matsunaga K; Kawabata H; Hirano T; Sugiura H; Minakata Y; Ichinose M
Pulm Pharmacol Ther; 2013 Apr; 26(2):189-94. PubMed ID: 23123925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
